| 摘要 |
Pharmaceutical product (I) comprises beta2 microglobulin (beta2m) or a functional variant of the protein, as the active ingredient. Independent claims are included for: (1) composition comprising (I); and (2) method of diagnosing an autoimmune disease, comprising determining the ratio of long chain (CL)/beta2m major histocompatibility complex (MHC) complex of type I extracted from a patient. ACTIVITY : Immunosuppressive; Antiarthritic; Antirheumatic; Antiinflammatory; Dermatological; Muscular-Gen.; Antidiabetic; Endocrine-Gen.; Gastrointestinal-Gen.; Neuroprotective. MECHANISM OF ACTION : None given. |
